Form 4: Axon Enterprise CPO & CTO Jeffrey Kunins Executes Stock Sales Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Jeffrey Kunins, CPO & CTO of Axon Enterprise, sold shares of common stock on September 9, 2024, under a pre-arranged Rule 10b5-1 trading plan, and also disposed of shares to cover tax liabilities from vesting restricted stock units.

Summary

  • On September 7, 2024, Jeffrey Kunins, the CPO & CTO of Axon Enterprise, disposed of 5,309 shares of common stock at a price of $354.62 to cover tax obligations related to vesting restricted stock units.
  • On September 9, 2024, Kunins sold a total of 8,182 shares of Axon Enterprise common stock in multiple transactions, with prices ranging from $362.9347 to $367.4381.
  • These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 15, 2024.
  • Following these transactions, Kunins directly owns 176,228 shares of Axon Enterprise common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing simply reports stock sales under a pre-existing 10b5-1 plan, which is a common practice. There's no indication of positive or negative implications for the company.

Industry Context

Insider trading activity is closely monitored and can influence investor sentiment. Sales under a 10b5-1 plan are generally viewed as less impactful since they are pre-arranged, but large or frequent sales can still raise concerns.

Comparison to Industry Standards

  • Comparing Kunins' transactions to other C-level executives in similar technology companies, the volume of shares sold is within a typical range for executives utilizing 10b5-1 plans for diversification or tax planning.
  • For example, executives at companies like Motorola Solutions (MSI) and Digital Ally (DGLY), which operate in related fields, also routinely use 10b5-1 plans for stock transactions.
  • The average sales price of Axon shares during these transactions is consistent with the stock's trading range during that period, indicating fair market value.

Stakeholder Impact

  • The stock sales could have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely minimal given the pre-planned nature of the sales and the relatively small volume compared to the total outstanding shares.

Key Dates

DateDescription
May 15, 2024Date the Rule 10b5-1 plan was adopted by the reporting person.
September 7, 2024Date of disposition of shares to cover tax liability.
September 9, 2024Date of stock sales executed under the Rule 10b5-1 plan.
September 10, 2024Date of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.